Marchesini Group invests in serialisation software and 3D printing

By Dan Stanton

- Last updated on GMT

Part of the firm's expansion includes 3D printing, a new facility for which is set to open in Bologna, Italy. Image c/o Marchesini Group
Part of the firm's expansion includes 3D printing, a new facility for which is set to open in Bologna, Italy. Image c/o Marchesini Group

Related tags Pharmacology

Pharma packaging firm Marchesini Group has acquired 48% of its serialisation software partner SEA Vision and forged a long-term agreement worth €125m.

The deal will see Italian packaging firm Marchesini Group own 48% of vision system software company SEA Vision, a firm they have partnered with on various projects in the past including for serialisation technology systems​.

“SEA Vision is really important for the Marchesini Group. In 35 years, this is the first M&A operation that involves not a mechanical firm but a softwarehouse,”​ Marchesini spokesperson Antonio Leggieri told in-Pharmatechnologist.

SEA Vision is a world point of reference for vision systems in the pharma industry,”​ and already their systems are present on 85% of the Marchesini machines, he said.

Leggieri did not reveal how much the company paid for the 48% share but said it is worth €125m ($156m) as a long-term strategic agreement between the two companies.

SEA Vision clocked in sales of €32m last year, but has predicted revenues to shoot up by 40% this year due to pharma serialization regulations across an increasing number of markets.

In the US, for example, a second-wave of track-and trace regulations came into effect last year​ and in Europe the Falsified Medicines Directive (EUFMD) makes serialisation of licensed drug products a legal requirement from early 2019.

3D printing

The Marchesini Group is also set to inaugurate a facility built entirely for 3D printing.

The 1,000m2​ factory, located within the firm’s headquartes in Pianoro, Bologna, represents an investment of between €5-6m and will be available to all customers.

“The parts printed are used for the customers’ machines,”​ said Leggieri. “The printers are also able to create prototypes, so the Group can develop them inside and not outside.”

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 09-Jun-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.